The end of compounded GLP-1 drugs leaves many patients in a ‘lose-lose’ position
djoldman Thursday, May 01, 2025
Summary
Patients seeking alternatives to the scarce weight-loss drug Wegovy (semaglutide) are turning to compounded GLP-1 drugs, which carry risks of inconsistent quality and safety. The article examines the growing demand for these compounded medications and the concerns raised by medical experts about their use.
29
33
Summary
statnews.com